Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
83.1M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
40.2M
-
Shares change
-
+341K
-
Total reported value, excl. options
-
$231M
-
Value change
-
-$1.58M
-
Put/Call ratio
-
0.15
-
Number of buys
-
51
-
Number of sells
-
-48
-
Price
-
$5.76
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 per share (ACET) as of Q1 2023
127 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Adicet Bio, Inc. - Common Stock, par value $0.0001 per share (ACET) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.2M shares
of 83.1M outstanding shares and own 48.45% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.45M shares), RTW INVESTMENTS, LP (4.24M shares), EcoR1 Capital, LLC (3.56M shares), COWEN AND COMPANY, LLC (3.14M shares), BlackRock Inc. (2.54M shares), TANG CAPITAL MANAGEMENT LLC (2.52M shares), Carlyle Group Inc. (2.12M shares), VANGUARD GROUP INC (1.69M shares), MORGAN STANLEY (1.64M shares), and Polar Capital Holdings Plc (1.26M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.